Insulin-like growth factor-1 is associated with cognitive outcome in infantile spasms

Epilepsia

Volumn 51, Issue 7, 2010, Pages 1283-1289

  Riikonen, Raili S ^a   Jääskeläinen, Jarmo ^a   Turpeinen, Ursula ^b  

^a KUOPIO UNIVERSITY HOSPITAL   (Finland)

^b HELSINKI UNIVERSITY CENTRAL HOSPITAL   (Finland)

Author keywords

Assessment of cognitive disorders dementia; Developmental disorders; EEG; Endocrine; Infantile spasms; Insulin like growth factor 1

Indexed keywords

CORTICOTROPIN; SOMATOMEDIN C;

ARTICLE; BLINDNESS; BRAIN ATROPHY; CEREBROSPINAL FLUID; CLINICAL ARTICLE; COGNITION; CONTROLLED STUDY; CONVULSION; CYTOMEGALOVIRUS INFECTION; FATIGUE; HEMIPLEGIC MIGRAINE; HUMAN; INFANT; INFANTILE SPASM; LEUKOMALACIA; MACROCEPHALY; MENTAL DEFICIENCY; NEURORADIOLOGY; OCULAR ALBINISM; OUTCOME ASSESSMENT; PRIORITY JOURNAL; STARTLE EPILEPSY; STRESS; TORTICOLLIS; TREATMENT RESPONSE; WERDNIG HOFFMANN DISEASE;

BIOLOGICAL MARKERS; CHILD, PRESCHOOL; COGNITION; COGNITION DISORDERS; HUMANS; INFANT; INSULIN-LIKE GROWTH FACTOR I; SPASMS, INFANTILE; STRESS, PSYCHOLOGICAL; TREATMENT OUTCOME;

EID: 77954508286     PISSN: 00139580     EISSN: 15281167     Source Type: Journal    
DOI: 10.1111/j.1528-1167.2009.02499.x     Document Type: Article

References (35)

1. Agha A, Monson J. (2007) Modulation of glucocorticoid metabolism by growth hormone - IGF-1 axis. Clin Endocrinol 66:459-465.
2. Avishai-Eliner S, Brunson K, Sandman C, Baram TZ. (2002) Stressed-out, or in (Utero)? Trends in Neurosci 25:518-529.
3. Baram TZ, Mitchell W, Snead O III, Hornton E, Saito M. (1992) Brainadrenal axis hormones are altered in the CSF of infantile spasms. Neurology 42:1171-1175.
4. Baram TZ. (2007) Models for infantile spasms: an arduous journey to the Holy Grail. Ann Neurol 61:89-90.
5. Beck K, Powell-Braxton L, Widmer H, Valverde J, Hefti F. (1995) Igf1 gene disruption results in reduced brain size, CNS hypomyelination, and loss of hippocampal granule and striatal parvalbumin-containing neurons. Neuron 14:717-730.
6. Blum W. (1993) Insulin-like growth factor-binding protein 3: Entwicklung eines Radioimmunoassays und Untersuchungen zur klinischen Bedeutung. Habilationsschrift, Kinderklinik der Universität Tubingen, p 21.
7. Bondanelli M, Ambrosio M, Onofri A, Bergonzoni A, Lavezzi S, Zatelli M, Valle D, Basaglia N, Degli Uberti E. (2006) Predictive value of circulating insulin-like growth factor levels in ischemic stroke outcome. J Clin Endocrinol Metab 91:3928-3934.
8. Brunson K, Khan N, Eghbal-Ahmadi M, Baram TZ. (2001) Corticotropin acts directly on amygdala neurons to down-regulate corticotrophin-releasing hormone gene expression. Ann Neurol 49:304-312.
9. Cheng C, Kelley B, Wang J, Strauss D, Eagles D, Bondy C. (2003) A ketogenic diet increases brain insulin-like growth factor receptor and glucose transporter gene expression. Endocrinology 144:2676-2682.
10. DÈrcole J, Ping Y. (2008) Minireview: Expanding the mind: Insulin-like growth factor I and brain development. Endocrinology 149:5958-5962.
11. Heine V, Maslam S, Zanero J, Joels M, Lucassen P. (2004) Suppressed proliferation and apoptotic changes in the rat dentate gyrus after acute and chronic stress is reversible. Eur Neurosci 19:131-144.
12. Heiskala H. (1997) CSF ACTH and beta-endorphin in infants with West syndrome and ACTH therapy. Brain Dev 10:339-342.
13. Huisman J, Aukema E, Deijen J, van Coeverden S, Caspers G, van der Pal H, Delemarre van der Waal H. (2008) The usefulness of growth hormone treatment for psychological status in young adult survivors of childhood leukaemia: an open-label study. BMC Pediatr 20:8-25.
14. ILEA Commission Report. (2001) A proposed diagnostic scheme for people with epileptic seizures and with epilepsy: a report of the ILEA task force on classification and terminology. Epilepsia 42:796-803.
15. Joels M, Karst H, Krugers H, Lucassen P. (2007) Chronic stress: implications for neuronal morphology functions and neurogenesis. Front Neuroendocrinol 28:72-96.
16. Joels M. (2009) Stress, the hippocampus, and epilepsy. Critical review and invited Commentary. Epilepsia 50:586-597.
17. Leventhal P, Russel J, Feldman E. (1999) IGFs and the nervous system. In Rosenfeld R, Roberts C Jr (Eds) The IGF system: molecular biology, physiology, and clinical applications. Humana Press, Totowa, pp. 425-444.
18. Lindholm D, Castren M, Hengerer B, Leingärtner A, Castren E, Thoenen H. (1994) Glucocorticoids and neurotrophin gene regulation in the nervous system. Ann NY Acad Sci USA 746:195-202.
19. Mochetti I, Spiga G, Hayes V, Isacksson P, Coangelo A. (1996) Glucocorticoids differentially increase nerve growth factor and basic fibroblast growth in rat brain. J Neurosci 16:214-218.
20. Nalin A, Facchinetti F, Galli V, Petraglia F, Storchi R, Genazzani A. (1985) Reduced ACTH concentrations in cerebrospinal fluid of children affected by cryptogenic infantile spasms and hypsarrhythmia. Epilepsia 26:446-449. (Pubitemid 16226444)
21. Pitkänen A. (2002) Drug-mediated neuroprotection and antiepileptogenesis; animal data. Neurology 59:S27-S33.
22. Popowski M, Ferguson H, Sion A, Koller E, Knudsen E, van den Berg C. (2008) Stress and IGF-1 differentially control cell fate through mammalian target of rapamycin (mTOR) and retinoblastoma protein (oRB). J Biol Chem 283:28265-28273.
23. Rener-Primec Z, Lozar-Krivec J, Krivec U, Neubauer D. (2006) Head growth in infants with infantile spasms may be temporarily reduced. Pediatr Neurol 35:197-203.
24. Rho J. (2004) Basic science behind the catastrophic epilepsies. Epilepsia 45(suppl 5):5-11.
25. Riikonen R. (1996) How do cryptogenic and symptomatic infantile spasms differ? A review of biochemical studies in Finnish patients J Child Neurol 11:383-388.
26. Riikonen R, Sçderstrçm S, Vanhala R, Ebendal T, Lindholm D. (1997) West's syndrome: cerebrospinal fluid nerve growth factor and effect of ACTH. Pediatr Neurol 17:224-229.
27. Riikonen R, Vettenranta K, Riikonen P, Turpeinen U, Saarinen-Pihkala U. (2004) Cerebrospinal fluid insulin-like growth factor (IGF-1) and insulin- like growth factor binding protein (IGFBP-3) in children with acute lymphoblastic leukaemia. Pediatr Blood Cancer 43:1-5.
28. Riikonen R, Makkonen I, Vanhala R, Kokki H, Turpeinen U, Kuikka J. (2006) Cerebrospinal fluid insulin-like growth factors IGF-1 and IGF-2 in infantile autism. Dev Med Child Neurol 48:751-755.
29. Riikonen R. (2007) Neurotrophic factors in the pathogenesis of neurological disorders with mental retardation. Current Pediatric Reviews 3:207-213.
30. Riikonen R. (2008) Insulin-like growth factors as neurobiological regulators of head growth in autism. In Zimmerman A (Ed) Autism: current theories and evidence. Humana Press, Totowa, pp. 233-244.
31. Tropea D, Giacometti E, Wilson NR, Beard C, McCurry C, Fu D, Flannery R, Jaenisch R, Sur M. (2009) Partial reversal of Rett syndrome-like symptoms in MECP2 mutant mice. Proc Natl Acad Sci USA 106:2029-2034.
32. Van der Reijden-Lakeman I, de Sonneville L, Swaab-Barneveld H, Slijper F, Verhulst F. (1997) Evaluation of attention before and after 2 years of growth hormone treatment in intrauterine growth retarded children. J Clin Exp Neuropsychol 19:101-118. (Pubitemid 27122107)
33. van Nieuwpoort C, Drent M. (2008) Cognition in the adult with childhood-onset growth hormone deficiency. Eur J Endocrinol 159(suppl 1):S53-S57.
34. Velisek L, Jehle K, Asche S, Veliskova J. (2007) Model of infantile spasms induced by N-methyl-D-aspartic acid in prenatally impaired brain. Ann Neurol 61:109-119.
35. Vigevano F, Fusco L, Cusmai R, Claps D, Ricci S, Milani L. (1993) The idiopathic form of West syndrome. Epilepsia 34:743-746.